Clinical trial

Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Surgery

NCT00373464 · Ullevaal University Hospital, Other · Completed

Key facts

NCT number NCT00373464
Title Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Surgery
Official title Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Gynaecologic Surgery With Expected Need of Post-operative Opioids
Lead sponsor Ullevaal University Hospital, Other
Collaborators Merck Sharp & Dohme LLC Industry University of Oslo
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hysterectomy, Tubal Excision, Ovariectomy, Postoperative Pain
Intervention type Drug
Interventions etoricoxib
Enrollment 126
Start date Mar 1, 2006
Completion Mar 1, 2007
First posted Sep 8, 2006
Last update posted Jul 1, 2011
Countries Norway

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies